Silver Book Fact

Early Gene Therapy Studies Show Promise for Parkinson’s Disease

Fact image

Lopes J. AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial. Parkinson's News Today. March 14 2019. https://parkinsonsnewstoday.com/2019/03/14/axo-lenti-pd-gene-therapy-shows-benefits-2-patients-phase-1-2-trial/. Accessed June 11, 2019

Christine C, Bankiewicz K, Van Laar A, Richardson R, et al. Magnetic Resonance Imaging-Guided Phase 1 Trial of Putanimal AADC Gene Therapy for Parkinson’s Disease. Ann Neurol. 2019; 85(5). https://www.onlinelibrary.wiley.com/doi/10.1002/ana.25450

Reference

Title
AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial
Publication
Parkinson's News Today
Publication Date
March 14 2019
Authors
Lopes J
URL
Read Full Resource
Title
Magnetic Resonance Imaging-Guided Phase 1 Trial of Putanimal AADC Gene Therapy for Parkinson’s Disease
Publication
Ann Neurol
Publication Date
2019
Authors
Christine C, Bankiewicz K, Van Laar A, Richardson R, et al.
Volume & Issue
Volume 85, Issue 5
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • An Alzheimer’s treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce out-of-pocket costs to people with the disease by $8 billion in 2020–from the…  
  • Willena is 75 and was diagnosed with Alzheimer’s disease five years ago Her daughter and primary caregiver, Wanda
    “Willena is 75 and was diagnosed with Alzheimer’s disease five years ago. Her daughter and primary caregiver, Wanda Richardson, believes that her mother went undiagnosed for at least 15 years…  
  • Spinal Cord Stimulation Shows Improvements for Parkinson’s Patients
     
  • Medicaid Costs, 5-Year Delayed Onset